nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A7—Temsirolimus—kidney cancer	0.0878	0.128	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0878	0.128	CbGbCtD
Eplerenone—CYP3A5—Temsirolimus—kidney cancer	0.0659	0.0963	CbGbCtD
Eplerenone—CYP3A4—Everolimus—kidney cancer	0.038	0.0556	CbGbCtD
Eplerenone—CYP3A7—Paclitaxel—kidney cancer	0.0301	0.0441	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0301	0.0441	CbGbCtD
Eplerenone—CYP3A7—Sorafenib—kidney cancer	0.0268	0.0391	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0268	0.0391	CbGbCtD
Eplerenone—CYP3A7—Vincristine—kidney cancer	0.026	0.038	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.026	0.038	CbGbCtD
Eplerenone—CYP3A4—Temsirolimus—kidney cancer	0.0257	0.0376	CbGbCtD
Eplerenone—CYP3A5—Erlotinib—kidney cancer	0.0247	0.0361	CbGbCtD
Eplerenone—CYP3A5—Paclitaxel—kidney cancer	0.0226	0.0331	CbGbCtD
Eplerenone—CYP3A7—Sunitinib—kidney cancer	0.0217	0.0317	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0217	0.0317	CbGbCtD
Eplerenone—NR3C2—collecting duct of renal tubule—kidney cancer	0.0209	0.369	CbGeAlD
Eplerenone—CYP3A5—Sorafenib—kidney cancer	0.0201	0.0294	CbGbCtD
Eplerenone—CYP3A5—Vincristine—kidney cancer	0.0195	0.0285	CbGbCtD
Eplerenone—CYP3A5—Sunitinib—kidney cancer	0.0163	0.0238	CbGbCtD
Eplerenone—CYP3A4—Pazopanib—kidney cancer	0.0135	0.0197	CbGbCtD
Eplerenone—CYP3A4—Erlotinib—kidney cancer	0.00963	0.0141	CbGbCtD
Eplerenone—NR3C2—nephron—kidney cancer	0.0093	0.164	CbGeAlD
Eplerenone—CYP3A4—Paclitaxel—kidney cancer	0.00881	0.0129	CbGbCtD
Eplerenone—CYP3A4—Sorafenib—kidney cancer	0.00783	0.0114	CbGbCtD
Eplerenone—CYP3A4—Vinblastine—kidney cancer	0.00773	0.0113	CbGbCtD
Eplerenone—CYP3A4—Vincristine—kidney cancer	0.0076	0.0111	CbGbCtD
Eplerenone—CYP3A4—Sunitinib—kidney cancer	0.00634	0.00928	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—kidney cancer	0.00475	0.00695	CbGbCtD
Eplerenone—CYP11B2—renal system—kidney cancer	0.00413	0.0731	CbGeAlD
Eplerenone—CYP3A4—urine—kidney cancer	0.00303	0.0535	CbGeAlD
Eplerenone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00262	0.0463	CbGeAlD
Eplerenone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00224	0.0397	CbGeAlD
Eplerenone—NR3C2—nephron tubule—kidney cancer	0.00201	0.0355	CbGeAlD
Eplerenone—NR3C2—renal system—kidney cancer	0.00182	0.0323	CbGeAlD
Eplerenone—NR3C2—kidney—kidney cancer	0.00176	0.0312	CbGeAlD
Eplerenone—NR3C2—cortex of kidney—kidney cancer	0.00172	0.0304	CbGeAlD
Eplerenone—NR3C2—cardiac atrium—kidney cancer	0.00163	0.0289	CbGeAlD
Eplerenone—CYP3A5—nephron tubule—kidney cancer	0.00108	0.0192	CbGeAlD
Eplerenone—Hydrocortisone—ANXA1—kidney cancer	0.00103	0.369	CrCbGaD
Eplerenone—CYP3A5—renal system—kidney cancer	0.000986	0.0174	CbGeAlD
Eplerenone—CYP3A5—kidney—kidney cancer	0.000954	0.0169	CbGeAlD
Eplerenone—CYP3A5—cortex of kidney—kidney cancer	0.000929	0.0164	CbGeAlD
Eplerenone—CYP3A4—renal system—kidney cancer	0.00074	0.0131	CbGeAlD
Eplerenone—CYP3A4—kidney—kidney cancer	0.000716	0.0126	CbGeAlD
Eplerenone—Drospirenone—BCHE—kidney cancer	0.000634	0.228	CrCbGaD
Eplerenone—Drospirenone—PTGS2—kidney cancer	0.000292	0.105	CrCbGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000193	0.0131	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—ACY1—kidney cancer	0.000187	0.0127	CbGpPWpGaD
Eplerenone—Progesterone—CYP1A1—kidney cancer	0.00018	0.0647	CrCbGaD
Eplerenone—NR3C2—Preimplantation Embryo—CDH1—kidney cancer	0.00018	0.0122	CbGpPWpGaD
Eplerenone—Spironolactone—ABCB1—kidney cancer	0.000177	0.0635	CrCbGaD
Eplerenone—Testosterone—CYP1A1—kidney cancer	0.00017	0.0611	CrCbGaD
Eplerenone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000167	0.0113	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000161	0.0109	CbGpPWpGaD
Eplerenone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000154	0.0105	CbGpPWpGaD
Eplerenone—CYP3A5—Irinotecan Pathway—APC—kidney cancer	0.000153	0.0104	CbGpPWpGaD
Eplerenone—Body temperature increased—Sunitinib—kidney cancer	0.000151	0.000624	CcSEcCtD
Eplerenone—Diarrhoea—Erlotinib—kidney cancer	0.000151	0.000624	CcSEcCtD
Eplerenone—Hypotension—Vincristine—kidney cancer	0.000151	0.000624	CcSEcCtD
Eplerenone—Nervous system disorder—Gemcitabine—kidney cancer	0.000151	0.000622	CcSEcCtD
Eplerenone—Feeling abnormal—Dactinomycin—kidney cancer	0.000149	0.000616	CcSEcCtD
Eplerenone—Skin disorder—Gemcitabine—kidney cancer	0.000149	0.000616	CcSEcCtD
Eplerenone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000148	0.000613	CcSEcCtD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000148	0.0101	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000148	0.000611	CcSEcCtD
Eplerenone—Hypoaesthesia—Capecitabine—kidney cancer	0.000148	0.00061	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000147	0.000609	CcSEcCtD
Eplerenone—Pharyngitis—Capecitabine—kidney cancer	0.000147	0.000608	CcSEcCtD
Eplerenone—CYP3A5—Xenobiotics—CYP1A1—kidney cancer	0.000147	0.00996	CbGpPWpGaD
Eplerenone—Urinary tract disorder—Capecitabine—kidney cancer	0.000147	0.000605	CcSEcCtD
Eplerenone—Insomnia—Vincristine—kidney cancer	0.000146	0.000604	CcSEcCtD
Eplerenone—Oedema peripheral—Capecitabine—kidney cancer	0.000146	0.000604	CcSEcCtD
Eplerenone—Vomiting—Vinblastine—kidney cancer	0.000146	0.000604	CcSEcCtD
Eplerenone—Dizziness—Erlotinib—kidney cancer	0.000146	0.000603	CcSEcCtD
Eplerenone—Ill-defined disorder—Paclitaxel—kidney cancer	0.000146	0.000603	CcSEcCtD
Eplerenone—Connective tissue disorder—Capecitabine—kidney cancer	0.000146	0.000602	CcSEcCtD
Eplerenone—Vomiting—Everolimus—kidney cancer	0.000146	0.000601	CcSEcCtD
Eplerenone—Anaemia—Paclitaxel—kidney cancer	0.000146	0.000601	CcSEcCtD
Eplerenone—Urethral disorder—Capecitabine—kidney cancer	0.000146	0.000601	CcSEcCtD
Eplerenone—Renal impairment—Doxorubicin—kidney cancer	0.000145	0.0006	CcSEcCtD
Eplerenone—Rash—Everolimus—kidney cancer	0.000144	0.000596	CcSEcCtD
Eplerenone—Dermatitis—Everolimus—kidney cancer	0.000144	0.000596	CcSEcCtD
Eplerenone—Headache—Vinblastine—kidney cancer	0.000144	0.000595	CcSEcCtD
Eplerenone—Angioedema—Paclitaxel—kidney cancer	0.000144	0.000594	CcSEcCtD
Eplerenone—Headache—Everolimus—kidney cancer	0.000144	0.000592	CcSEcCtD
Eplerenone—Hypotension—Gemcitabine—kidney cancer	0.000143	0.000592	CcSEcCtD
Eplerenone—Abdominal pain—Dactinomycin—kidney cancer	0.000143	0.000591	CcSEcCtD
Eplerenone—Body temperature increased—Dactinomycin—kidney cancer	0.000143	0.000591	CcSEcCtD
Eplerenone—Asthenia—Sorafenib—kidney cancer	0.000143	0.000589	CcSEcCtD
Eplerenone—Malaise—Paclitaxel—kidney cancer	0.000142	0.000586	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—GSTT1—kidney cancer	0.000142	0.00962	CbGpPWpGaD
Eplerenone—Syncope—Paclitaxel—kidney cancer	0.000141	0.000583	CcSEcCtD
Eplerenone—CYP3A5—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000141	0.00958	CbGpPWpGaD
Eplerenone—Pruritus—Sorafenib—kidney cancer	0.000141	0.000581	CcSEcCtD
Eplerenone—Vomiting—Erlotinib—kidney cancer	0.000141	0.00058	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00014	0.000577	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Vincristine—kidney cancer	0.00014	0.000577	CcSEcCtD
Eplerenone—Fatigue—Vincristine—kidney cancer	0.00014	0.000576	CcSEcCtD
Eplerenone—Rash—Erlotinib—kidney cancer	0.000139	0.000575	CcSEcCtD
Eplerenone—Dermatitis—Erlotinib—kidney cancer	0.000139	0.000575	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000139	0.00945	CbGpPWpGaD
Eplerenone—Hyponatraemia—Doxorubicin—kidney cancer	0.000139	0.000573	CcSEcCtD
Eplerenone—Insomnia—Gemcitabine—kidney cancer	0.000139	0.000573	CcSEcCtD
Eplerenone—Headache—Erlotinib—kidney cancer	0.000138	0.000572	CcSEcCtD
Eplerenone—Tinnitus—Capecitabine—kidney cancer	0.000138	0.000572	CcSEcCtD
Eplerenone—Loss of consciousness—Paclitaxel—kidney cancer	0.000138	0.000571	CcSEcCtD
Eplerenone—Constipation—Vincristine—kidney cancer	0.000138	0.000571	CcSEcCtD
Eplerenone—Pain—Vincristine—kidney cancer	0.000138	0.000571	CcSEcCtD
Eplerenone—Flushing—Capecitabine—kidney cancer	0.000138	0.000569	CcSEcCtD
Eplerenone—Cardiac disorder—Capecitabine—kidney cancer	0.000138	0.000569	CcSEcCtD
Eplerenone—Cough—Paclitaxel—kidney cancer	0.000137	0.000567	CcSEcCtD
Eplerenone—Asthenia—Sunitinib—kidney cancer	0.000137	0.000567	CcSEcCtD
Eplerenone—Dyspnoea—Gemcitabine—kidney cancer	0.000137	0.000565	CcSEcCtD
Eplerenone—Nausea—Vinblastine—kidney cancer	0.000137	0.000564	CcSEcCtD
Eplerenone—Nausea—Everolimus—kidney cancer	0.000136	0.000562	CcSEcCtD
Eplerenone—Diarrhoea—Sorafenib—kidney cancer	0.000136	0.000562	CcSEcCtD
Eplerenone—Pruritus—Sunitinib—kidney cancer	0.000135	0.000559	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—ACY1—kidney cancer	0.000135	0.00916	CbGpPWpGaD
Eplerenone—Angiopathy—Capecitabine—kidney cancer	0.000135	0.000556	CcSEcCtD
Eplerenone—Myalgia—Paclitaxel—kidney cancer	0.000134	0.000554	CcSEcCtD
Eplerenone—Chest pain—Paclitaxel—kidney cancer	0.000134	0.000554	CcSEcCtD
Eplerenone—Arthralgia—Paclitaxel—kidney cancer	0.000134	0.000554	CcSEcCtD
Eplerenone—Mediastinal disorder—Capecitabine—kidney cancer	0.000134	0.000552	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000133	0.00055	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—PTGS1—kidney cancer	0.000133	0.00902	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000133	0.000547	CcSEcCtD
Eplerenone—Discomfort—Paclitaxel—kidney cancer	0.000133	0.000547	CcSEcCtD
Eplerenone—Fatigue—Gemcitabine—kidney cancer	0.000132	0.000546	CcSEcCtD
Eplerenone—Gastrointestinal pain—Vincristine—kidney cancer	0.000132	0.000546	CcSEcCtD
Eplerenone—Dizziness—Sorafenib—kidney cancer	0.000132	0.000543	CcSEcCtD
Eplerenone—Constipation—Gemcitabine—kidney cancer	0.000131	0.000542	CcSEcCtD
Eplerenone—Pain—Gemcitabine—kidney cancer	0.000131	0.000542	CcSEcCtD
Eplerenone—Nausea—Erlotinib—kidney cancer	0.000131	0.000542	CcSEcCtD
Eplerenone—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000131	0.00889	CbGpPWpGaD
Eplerenone—Diarrhoea—Sunitinib—kidney cancer	0.000131	0.00054	CcSEcCtD
Eplerenone—Mental disorder—Capecitabine—kidney cancer	0.00013	0.000537	CcSEcCtD
Eplerenone—Asthenia—Dactinomycin—kidney cancer	0.00013	0.000537	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—kidney cancer	0.00013	0.000535	CcSEcCtD
Eplerenone—Malnutrition—Capecitabine—kidney cancer	0.000129	0.000534	CcSEcCtD
Eplerenone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000129	0.00877	CbGpPWpGaD
Eplerenone—Dehydration—Doxorubicin—kidney cancer	0.000129	0.000531	CcSEcCtD
Eplerenone—Body temperature increased—Vincristine—kidney cancer	0.000128	0.000528	CcSEcCtD
Eplerenone—Abdominal pain—Vincristine—kidney cancer	0.000128	0.000528	CcSEcCtD
Eplerenone—Infection—Paclitaxel—kidney cancer	0.000128	0.000527	CcSEcCtD
Eplerenone—Flatulence—Capecitabine—kidney cancer	0.000127	0.000526	CcSEcCtD
Eplerenone—Dizziness—Sunitinib—kidney cancer	0.000127	0.000522	CcSEcCtD
Eplerenone—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000522	CcSEcCtD
Eplerenone—Shock—Paclitaxel—kidney cancer	0.000126	0.000522	CcSEcCtD
Eplerenone—Vomiting—Sorafenib—kidney cancer	0.000126	0.000522	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000126	0.000522	CcSEcCtD
Eplerenone—Nervous system disorder—Paclitaxel—kidney cancer	0.000126	0.00052	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—kidney cancer	0.000126	0.00052	CcSEcCtD
Eplerenone—Rash—Sorafenib—kidney cancer	0.000125	0.000518	CcSEcCtD
Eplerenone—Dermatitis—Sorafenib—kidney cancer	0.000125	0.000517	CcSEcCtD
Eplerenone—Back pain—Capecitabine—kidney cancer	0.000125	0.000516	CcSEcCtD
Eplerenone—Skin disorder—Paclitaxel—kidney cancer	0.000125	0.000515	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000125	0.000514	CcSEcCtD
Eplerenone—Headache—Sorafenib—kidney cancer	0.000125	0.000514	CcSEcCtD
Eplerenone—Muscle spasms—Capecitabine—kidney cancer	0.000124	0.000513	CcSEcCtD
Eplerenone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000124	0.000513	CcSEcCtD
Eplerenone—Diarrhoea—Dactinomycin—kidney cancer	0.000124	0.000512	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000122	0.000504	CcSEcCtD
Eplerenone—Vomiting—Sunitinib—kidney cancer	0.000122	0.000502	CcSEcCtD
Eplerenone—Body temperature increased—Gemcitabine—kidney cancer	0.000121	0.000501	CcSEcCtD
Eplerenone—Rash—Sunitinib—kidney cancer	0.000121	0.000498	CcSEcCtD
Eplerenone—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000498	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00012	0.00815	CbGpPWpGaD
Eplerenone—Hypotension—Paclitaxel—kidney cancer	0.00012	0.000496	CcSEcCtD
Eplerenone—Ill-defined disorder—Capecitabine—kidney cancer	0.00012	0.000495	CcSEcCtD
Eplerenone—Headache—Sunitinib—kidney cancer	0.00012	0.000495	CcSEcCtD
Eplerenone—Anaemia—Capecitabine—kidney cancer	0.000119	0.000493	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—HARS—kidney cancer	0.000118	0.00804	CbGpPWpGaD
Eplerenone—Eosinophilia—Doxorubicin—kidney cancer	0.000118	0.000489	CcSEcCtD
Eplerenone—Nausea—Sorafenib—kidney cancer	0.000118	0.000488	CcSEcCtD
Eplerenone—Hydrocortisone—ABCB1—kidney cancer	0.000118	0.0422	CrCbGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000117	0.00795	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000117	0.000483	CcSEcCtD
Eplerenone—Malaise—Capecitabine—kidney cancer	0.000117	0.000481	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—kidney cancer	0.000116	0.000481	CcSEcCtD
Eplerenone—Insomnia—Paclitaxel—kidney cancer	0.000116	0.00048	CcSEcCtD
Eplerenone—Asthenia—Vincristine—kidney cancer	0.000116	0.000479	CcSEcCtD
Eplerenone—Syncope—Capecitabine—kidney cancer	0.000116	0.000479	CcSEcCtD
Eplerenone—Vomiting—Dactinomycin—kidney cancer	0.000115	0.000475	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—kidney cancer	0.000115	0.000475	CcSEcCtD
Eplerenone—Dyspnoea—Paclitaxel—kidney cancer	0.000115	0.000473	CcSEcCtD
Eplerenone—Rash—Dactinomycin—kidney cancer	0.000114	0.000472	CcSEcCtD
Eplerenone—Nausea—Sunitinib—kidney cancer	0.000114	0.000469	CcSEcCtD
Eplerenone—Loss of consciousness—Capecitabine—kidney cancer	0.000114	0.000469	CcSEcCtD
Eplerenone—Dyspepsia—Paclitaxel—kidney cancer	0.000113	0.000467	CcSEcCtD
Eplerenone—Cough—Capecitabine—kidney cancer	0.000113	0.000466	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000111	0.000459	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000111	0.000458	CcSEcCtD
Eplerenone—Fatigue—Paclitaxel—kidney cancer	0.000111	0.000458	CcSEcCtD
Eplerenone—Diarrhoea—Vincristine—kidney cancer	0.000111	0.000457	CcSEcCtD
Eplerenone—Asthenia—Gemcitabine—kidney cancer	0.00011	0.000455	CcSEcCtD
Eplerenone—Arthralgia—Capecitabine—kidney cancer	0.00011	0.000454	CcSEcCtD
Eplerenone—Myalgia—Capecitabine—kidney cancer	0.00011	0.000454	CcSEcCtD
Eplerenone—Chest pain—Capecitabine—kidney cancer	0.00011	0.000454	CcSEcCtD
Eplerenone—Pain—Paclitaxel—kidney cancer	0.00011	0.000454	CcSEcCtD
Eplerenone—Constipation—Paclitaxel—kidney cancer	0.00011	0.000454	CcSEcCtD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00011	0.00743	CbGpPWpGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000109	0.000451	CcSEcCtD
Eplerenone—Discomfort—Capecitabine—kidney cancer	0.000109	0.000449	CcSEcCtD
Eplerenone—Pruritus—Gemcitabine—kidney cancer	0.000109	0.000448	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—kidney cancer	0.000108	0.000445	CcSEcCtD
Eplerenone—Nausea—Dactinomycin—kidney cancer	0.000108	0.000444	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—kidney cancer	0.000107	0.000443	CcSEcCtD
Eplerenone—Dizziness—Vincristine—kidney cancer	0.000107	0.000442	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—kidney cancer	0.000107	0.00044	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—kidney cancer	0.000107	0.00044	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000106	0.0072	CbGpPWpGaD
Eplerenone—Feeling abnormal—Paclitaxel—kidney cancer	0.000106	0.000437	CcSEcCtD
Eplerenone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000105	0.000434	CcSEcCtD
Eplerenone—Diarrhoea—Gemcitabine—kidney cancer	0.000105	0.000434	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—kidney cancer	0.000105	0.000433	CcSEcCtD
Eplerenone—Infection—Capecitabine—kidney cancer	0.000105	0.000433	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000105	0.000431	CcSEcCtD
Eplerenone—Shock—Capecitabine—kidney cancer	0.000104	0.000428	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—kidney cancer	0.000104	0.000428	CcSEcCtD
Eplerenone—Nervous system disorder—Capecitabine—kidney cancer	0.000103	0.000427	CcSEcCtD
Eplerenone—Vomiting—Vincristine—kidney cancer	0.000103	0.000425	CcSEcCtD
Eplerenone—Skin disorder—Capecitabine—kidney cancer	0.000102	0.000423	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ALDH1A1—kidney cancer	0.000102	0.00694	CbGpPWpGaD
Eplerenone—Rash—Vincristine—kidney cancer	0.000102	0.000421	CcSEcCtD
Eplerenone—Hyperhidrosis—Capecitabine—kidney cancer	0.000102	0.000421	CcSEcCtD
Eplerenone—Dermatitis—Vincristine—kidney cancer	0.000102	0.000421	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—kidney cancer	0.000102	0.00042	CcSEcCtD
Eplerenone—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.00042	CcSEcCtD
Eplerenone—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.00042	CcSEcCtD
Eplerenone—Headache—Vincristine—kidney cancer	0.000101	0.000419	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000101	0.000416	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—EIF5B—kidney cancer	0.000101	0.00684	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	9.88e-05	0.0067	CbGpPWpGaD
Eplerenone—Hypotension—Capecitabine—kidney cancer	9.86e-05	0.000407	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—GSTP1—kidney cancer	9.83e-05	0.00667	CbGpPWpGaD
Eplerenone—Vomiting—Gemcitabine—kidney cancer	9.76e-05	0.000403	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTP1—kidney cancer	9.69e-05	0.00658	CbGpPWpGaD
Eplerenone—Rash—Gemcitabine—kidney cancer	9.68e-05	0.0004	CcSEcCtD
Eplerenone—Dermatitis—Gemcitabine—kidney cancer	9.67e-05	0.000399	CcSEcCtD
Eplerenone—Headache—Gemcitabine—kidney cancer	9.62e-05	0.000397	CcSEcCtD
Eplerenone—Nausea—Vincristine—kidney cancer	9.61e-05	0.000397	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.61e-05	0.000397	CcSEcCtD
Eplerenone—Progesterone—ABCB1—kidney cancer	9.58e-05	0.0344	CrCbGaD
Eplerenone—Insomnia—Capecitabine—kidney cancer	9.54e-05	0.000394	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—kidney cancer	9.52e-05	0.000393	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—kidney cancer	9.5e-05	0.000392	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—kidney cancer	9.45e-05	0.00039	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—kidney cancer	9.43e-05	0.000389	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—kidney cancer	9.41e-05	0.000388	CcSEcCtD
Eplerenone—Dyspnoea—Capecitabine—kidney cancer	9.41e-05	0.000388	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—kidney cancer	9.38e-05	0.000387	CcSEcCtD
Eplerenone—Dyspepsia—Capecitabine—kidney cancer	9.29e-05	0.000383	CcSEcCtD
Eplerenone—Asthenia—Paclitaxel—kidney cancer	9.22e-05	0.000381	CcSEcCtD
Eplerenone—Nausea—Gemcitabine—kidney cancer	9.12e-05	0.000376	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Capecitabine—kidney cancer	9.11e-05	0.000376	CcSEcCtD
Eplerenone—Fatigue—Capecitabine—kidney cancer	9.1e-05	0.000375	CcSEcCtD
Eplerenone—Pruritus—Paclitaxel—kidney cancer	9.1e-05	0.000375	CcSEcCtD
Eplerenone—Testosterone—ABCB1—kidney cancer	9.05e-05	0.0325	CrCbGaD
Eplerenone—CYP11B2—Biological oxidations—GSTM1—kidney cancer	9.03e-05	0.00613	CbGpPWpGaD
Eplerenone—Pain—Capecitabine—kidney cancer	9.02e-05	0.000372	CcSEcCtD
Eplerenone—Constipation—Capecitabine—kidney cancer	9.02e-05	0.000372	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—kidney cancer	8.93e-05	0.000368	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTM1—kidney cancer	8.91e-05	0.00604	CbGpPWpGaD
Eplerenone—Cardiac disorder—Doxorubicin—kidney cancer	8.88e-05	0.000367	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—kidney cancer	8.88e-05	0.000367	CcSEcCtD
Eplerenone—Diarrhoea—Paclitaxel—kidney cancer	8.8e-05	0.000363	CcSEcCtD
Eplerenone—Feeling abnormal—Capecitabine—kidney cancer	8.69e-05	0.000359	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—kidney cancer	8.69e-05	0.000358	CcSEcCtD
Eplerenone—Gastrointestinal pain—Capecitabine—kidney cancer	8.63e-05	0.000356	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—kidney cancer	8.63e-05	0.000356	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP1A1—kidney cancer	8.56e-05	0.00581	CbGpPWpGaD
Eplerenone—Dizziness—Paclitaxel—kidney cancer	8.5e-05	0.000351	CcSEcCtD
Eplerenone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	8.44e-05	0.00573	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP1A1—kidney cancer	8.44e-05	0.00573	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.43e-05	0.00572	CbGpPWpGaD
Eplerenone—Mental disorder—Doxorubicin—kidney cancer	8.39e-05	0.000346	CcSEcCtD
Eplerenone—Abdominal pain—Capecitabine—kidney cancer	8.34e-05	0.000344	CcSEcCtD
Eplerenone—Body temperature increased—Capecitabine—kidney cancer	8.34e-05	0.000344	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—kidney cancer	8.33e-05	0.000344	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.32e-05	0.00565	CbGpPWpGaD
Eplerenone—Flatulence—Doxorubicin—kidney cancer	8.21e-05	0.000339	CcSEcCtD
Eplerenone—Vomiting—Paclitaxel—kidney cancer	8.17e-05	0.000337	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	8.16e-05	0.00554	CbGpPWpGaD
Eplerenone—Rash—Paclitaxel—kidney cancer	8.11e-05	0.000335	CcSEcCtD
Eplerenone—Dermatitis—Paclitaxel—kidney cancer	8.1e-05	0.000334	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—kidney cancer	8.06e-05	0.000333	CcSEcCtD
Eplerenone—Headache—Paclitaxel—kidney cancer	8.05e-05	0.000332	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—kidney cancer	8.01e-05	0.000331	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	7.83e-05	0.00531	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Doxorubicin—kidney cancer	7.73e-05	0.000319	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—kidney cancer	7.7e-05	0.000318	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.67e-05	0.0052	CbGpPWpGaD
Eplerenone—Nausea—Paclitaxel—kidney cancer	7.64e-05	0.000315	CcSEcCtD
Eplerenone—Asthenia—Capecitabine—kidney cancer	7.57e-05	0.000312	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ACY1—kidney cancer	7.53e-05	0.00511	CbGpPWpGaD
Eplerenone—Malaise—Doxorubicin—kidney cancer	7.51e-05	0.00031	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—kidney cancer	7.47e-05	0.000308	CcSEcCtD
Eplerenone—Pruritus—Capecitabine—kidney cancer	7.46e-05	0.000308	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	7.42e-05	0.00504	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	7.4e-05	0.00502	CbGpPWpGaD
Eplerenone—Loss of consciousness—Doxorubicin—kidney cancer	7.32e-05	0.000302	CcSEcCtD
Eplerenone—Cough—Doxorubicin—kidney cancer	7.27e-05	0.0003	CcSEcCtD
Eplerenone—Diarrhoea—Capecitabine—kidney cancer	7.22e-05	0.000298	CcSEcCtD
Eplerenone—CYP3A4—Irinotecan Pathway—APC—kidney cancer	7.11e-05	0.00482	CbGpPWpGaD
Eplerenone—Arthralgia—Doxorubicin—kidney cancer	7.09e-05	0.000293	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—kidney cancer	7.09e-05	0.000293	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—kidney cancer	7.09e-05	0.000293	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.05e-05	0.000291	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—kidney cancer	7.01e-05	0.000289	CcSEcCtD
Eplerenone—Dizziness—Capecitabine—kidney cancer	6.98e-05	0.000288	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.83e-05	0.00464	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	6.82e-05	0.00463	CbGpPWpGaD
Eplerenone—Infection—Doxorubicin—kidney cancer	6.76e-05	0.000279	CcSEcCtD
Eplerenone—Vomiting—Capecitabine—kidney cancer	6.71e-05	0.000277	CcSEcCtD
Eplerenone—Shock—Doxorubicin—kidney cancer	6.69e-05	0.000276	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—kidney cancer	6.67e-05	0.000275	CcSEcCtD
Eplerenone—Rash—Capecitabine—kidney cancer	6.65e-05	0.000275	CcSEcCtD
Eplerenone—Dermatitis—Capecitabine—kidney cancer	6.65e-05	0.000274	CcSEcCtD
Eplerenone—Headache—Capecitabine—kidney cancer	6.61e-05	0.000273	CcSEcCtD
Eplerenone—Skin disorder—Doxorubicin—kidney cancer	6.61e-05	0.000273	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—kidney cancer	6.57e-05	0.000271	CcSEcCtD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	6.56e-05	0.00445	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—JUNB—kidney cancer	6.54e-05	0.00444	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—EEF2—kidney cancer	6.49e-05	0.0044	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	6.47e-05	0.00439	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.42e-05	0.00436	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PDHB—kidney cancer	6.4e-05	0.00435	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—POMC—kidney cancer	6.38e-05	0.00433	CbGpPWpGaD
Eplerenone—Hypotension—Doxorubicin—kidney cancer	6.35e-05	0.000262	CcSEcCtD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.29e-05	0.00427	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ACY1—kidney cancer	6.28e-05	0.00426	CbGpPWpGaD
Eplerenone—Nausea—Capecitabine—kidney cancer	6.27e-05	0.000259	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—TET2—kidney cancer	6.22e-05	0.00422	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.2e-05	0.000256	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—kidney cancer	6.15e-05	0.000254	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.09e-05	0.00414	CbGpPWpGaD
Eplerenone—Dyspnoea—Doxorubicin—kidney cancer	6.06e-05	0.00025	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CCBL1—kidney cancer	6.02e-05	0.00409	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.01e-05	0.00408	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTT1—kidney cancer	6.01e-05	0.00408	CbGpPWpGaD
Eplerenone—Dyspepsia—Doxorubicin—kidney cancer	5.99e-05	0.000247	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.87e-05	0.000242	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—kidney cancer	5.86e-05	0.000242	CcSEcCtD
Eplerenone—Pain—Doxorubicin—kidney cancer	5.82e-05	0.00024	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—kidney cancer	5.82e-05	0.00024	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—TCEB2—kidney cancer	5.69e-05	0.00386	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—TCEB1—kidney cancer	5.69e-05	0.00386	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—PTGS1—kidney cancer	5.63e-05	0.00382	CbGpPWpGaD
Eplerenone—Feeling abnormal—Doxorubicin—kidney cancer	5.6e-05	0.000231	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—kidney cancer	5.56e-05	0.00023	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.44e-05	0.00369	CbGpPWpGaD
Eplerenone—Body temperature increased—Doxorubicin—kidney cancer	5.38e-05	0.000222	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—kidney cancer	5.38e-05	0.000222	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—CDKN2B—kidney cancer	5.32e-05	0.00361	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPAT—kidney cancer	5.22e-05	0.00354	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GLIPR1—kidney cancer	5.22e-05	0.00354	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.15e-05	0.0035	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.1e-05	0.00346	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.1e-05	0.00346	CbGpPWpGaD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	5.09e-05	0.00345	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.94e-05	0.00335	CbGpPWpGaD
Eplerenone—Asthenia—Doxorubicin—kidney cancer	4.88e-05	0.000201	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—APRT—kidney cancer	4.85e-05	0.00329	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—FH—kidney cancer	4.85e-05	0.00329	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	4.85e-05	0.00329	CbGpPWpGaD
Eplerenone—Pruritus—Doxorubicin—kidney cancer	4.81e-05	0.000199	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.74e-05	0.00322	CbGpPWpGaD
Eplerenone—Diarrhoea—Doxorubicin—kidney cancer	4.65e-05	0.000192	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—RPL14—kidney cancer	4.62e-05	0.00314	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GPC3—kidney cancer	4.56e-05	0.0031	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.54e-05	0.00308	CbGpPWpGaD
Eplerenone—Dizziness—Doxorubicin—kidney cancer	4.5e-05	0.000186	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CA2—kidney cancer	4.44e-05	0.00301	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTT1—kidney cancer	4.35e-05	0.00295	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALAD—kidney cancer	4.33e-05	0.00294	CbGpPWpGaD
Eplerenone—Vomiting—Doxorubicin—kidney cancer	4.32e-05	0.000178	CcSEcCtD
Eplerenone—Rash—Doxorubicin—kidney cancer	4.29e-05	0.000177	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—kidney cancer	4.28e-05	0.000177	CcSEcCtD
Eplerenone—Headache—Doxorubicin—kidney cancer	4.26e-05	0.000176	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ST3GAL2—kidney cancer	4.22e-05	0.00286	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—kidney cancer	4.17e-05	0.00283	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDH1A1—kidney cancer	4.13e-05	0.0028	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—kidney cancer	4.11e-05	0.00279	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—PTGS1—kidney cancer	4.07e-05	0.00276	CbGpPWpGaD
Eplerenone—Nausea—Doxorubicin—kidney cancer	4.04e-05	0.000167	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—SLC5A3—kidney cancer	3.96e-05	0.00268	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PGK1—kidney cancer	3.96e-05	0.00268	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—LDHB—kidney cancer	3.88e-05	0.00263	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTM1—kidney cancer	3.83e-05	0.0026	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTM1—kidney cancer	3.78e-05	0.00256	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—HSPB1—kidney cancer	3.77e-05	0.00256	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—EIF4EBP1—kidney cancer	3.77e-05	0.00256	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.68e-05	0.0025	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP1A1—kidney cancer	3.63e-05	0.00246	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP1A1—kidney cancer	3.58e-05	0.00243	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.56e-05	0.00242	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PSMD7—kidney cancer	3.5e-05	0.00238	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	3.5e-05	0.00238	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	3.44e-05	0.00233	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CA9—kidney cancer	3.36e-05	0.00228	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.29e-05	0.00223	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ACY1—kidney cancer	3.19e-05	0.00217	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—JUNB—kidney cancer	3.15e-05	0.00214	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—kidney cancer	3.01e-05	0.00204	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	2.97e-05	0.00202	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CRABP1—kidney cancer	2.86e-05	0.00194	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	2.83e-05	0.00192	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.8e-05	0.0019	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTM1—kidney cancer	2.77e-05	0.00188	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	2.73e-05	0.00185	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PDHB—kidney cancer	2.72e-05	0.00184	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—POMC—kidney cancer	2.71e-05	0.00184	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ITPR2—kidney cancer	2.66e-05	0.0018	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	2.62e-05	0.00178	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	2.59e-05	0.00176	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—CDKN2B—kidney cancer	2.56e-05	0.00174	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CCBL1—kidney cancer	2.55e-05	0.00173	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.45e-05	0.00166	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTT1—kidney cancer	2.42e-05	0.00165	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ACHE—kidney cancer	2.42e-05	0.00165	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ACY1—kidney cancer	2.31e-05	0.00157	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.3e-05	0.00156	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SCARB1—kidney cancer	2.3e-05	0.00156	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS1—kidney cancer	2.27e-05	0.00154	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PSMD7—kidney cancer	2.23e-05	0.00151	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GLIPR1—kidney cancer	2.21e-05	0.0015	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPAT—kidney cancer	2.21e-05	0.0015	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.11e-05	0.00143	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—BCHE—kidney cancer	2.11e-05	0.00143	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC5A5—kidney cancer	2.09e-05	0.00142	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—kidney cancer	2.06e-05	0.0014	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—APRT—kidney cancer	2.06e-05	0.0014	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—FH—kidney cancer	2.06e-05	0.0014	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.02e-05	0.00137	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC2A1—kidney cancer	2.02e-05	0.00137	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PDHB—kidney cancer	1.96e-05	0.00133	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—POMC—kidney cancer	1.96e-05	0.00133	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.96e-05	0.00133	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GPC3—kidney cancer	1.93e-05	0.00131	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.89e-05	0.00128	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CA2—kidney cancer	1.88e-05	0.00128	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CCBL1—kidney cancer	1.85e-05	0.00125	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALAD—kidney cancer	1.83e-05	0.00124	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ST3GAL2—kidney cancer	1.79e-05	0.00121	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDH1A1—kidney cancer	1.75e-05	0.00119	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.71e-05	0.00116	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.71e-05	0.00116	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—kidney cancer	1.68e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PGK1—kidney cancer	1.68e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC5A3—kidney cancer	1.68e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—LDHB—kidney cancer	1.65e-05	0.00112	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GLIPR1—kidney cancer	1.6e-05	0.00109	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPAT—kidney cancer	1.6e-05	0.00109	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ABCB1—kidney cancer	1.59e-05	0.00108	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTM1—kidney cancer	1.54e-05	0.00105	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—FH—kidney cancer	1.49e-05	0.00101	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—APRT—kidney cancer	1.49e-05	0.00101	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP1A1—kidney cancer	1.46e-05	0.000994	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CA9—kidney cancer	1.43e-05	0.000968	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.4e-05	0.00095	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GPC3—kidney cancer	1.4e-05	0.000949	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.38e-05	0.000937	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CA2—kidney cancer	1.36e-05	0.000923	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALAD—kidney cancer	1.33e-05	0.0009	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.29e-05	0.000878	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.29e-05	0.000873	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.27e-05	0.000861	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.26e-05	0.000858	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.22e-05	0.000828	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000823	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.21e-05	0.000823	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PGK1—kidney cancer	1.21e-05	0.000823	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.2e-05	0.000817	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-05	0.000816	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LDHB—kidney cancer	1.19e-05	0.000807	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ITPR2—kidney cancer	1.13e-05	0.000765	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—POMC—kidney cancer	1.09e-05	0.000741	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ACY1—kidney cancer	1.07e-05	0.000728	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CA9—kidney cancer	1.03e-05	0.0007	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—kidney cancer	1.03e-05	0.000698	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ACHE—kidney cancer	1.03e-05	0.000698	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MAPK3—kidney cancer	1.02e-05	0.000693	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—kidney cancer	9.93e-06	0.000674	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SCARB1—kidney cancer	9.73e-06	0.000661	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS1—kidney cancer	9.64e-06	0.000654	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PSMD7—kidney cancer	9.45e-06	0.000641	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PDHB—kidney cancer	9.13e-06	0.000619	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—POMC—kidney cancer	9.1e-06	0.000617	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—BCHE—kidney cancer	8.96e-06	0.000608	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC5A5—kidney cancer	8.85e-06	0.0006	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CRABP1—kidney cancer	8.77e-06	0.000595	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—kidney cancer	8.71e-06	0.000591	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CCBL1—kidney cancer	8.58e-06	0.000582	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC2A1—kidney cancer	8.55e-06	0.00058	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ITPR2—kidney cancer	8.15e-06	0.000553	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—kidney cancer	7.59e-06	0.000515	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPAT—kidney cancer	7.44e-06	0.000505	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.44e-06	0.000505	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—kidney cancer	7.43e-06	0.000504	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ACHE—kidney cancer	7.43e-06	0.000504	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—kidney cancer	7.13e-06	0.000484	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SCARB1—kidney cancer	7.04e-06	0.000477	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS1—kidney cancer	6.97e-06	0.000473	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—FH—kidney cancer	6.92e-06	0.000469	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—APRT—kidney cancer	6.92e-06	0.000469	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PSMD7—kidney cancer	6.83e-06	0.000464	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ABCB1—kidney cancer	6.75e-06	0.000458	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—kidney cancer	6.55e-06	0.000444	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GPC3—kidney cancer	6.5e-06	0.000441	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—BCHE—kidney cancer	6.48e-06	0.000439	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.4e-06	0.000434	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CA2—kidney cancer	6.33e-06	0.000429	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.21e-06	0.000421	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.18e-06	0.000419	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALAD—kidney cancer	6.16e-06	0.000418	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.02e-06	0.000408	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.88e-06	0.000399	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.64e-06	0.000383	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PGK1—kidney cancer	5.64e-06	0.000383	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LDHB—kidney cancer	5.53e-06	0.000375	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—kidney cancer	5.36e-06	0.000364	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—kidney cancer	5.15e-06	0.00035	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCB1—kidney cancer	4.88e-06	0.000331	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CA9—kidney cancer	4.79e-06	0.000325	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—kidney cancer	4.73e-06	0.000321	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—POMC—kidney cancer	4.63e-06	0.000314	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.49e-06	0.000305	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CRABP1—kidney cancer	4.08e-06	0.000277	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ITPR2—kidney cancer	3.79e-06	0.000257	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—kidney cancer	3.69e-06	0.000251	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—kidney cancer	3.46e-06	0.000235	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ACHE—kidney cancer	3.46e-06	0.000235	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—POMC—kidney cancer	3.35e-06	0.000227	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SCARB1—kidney cancer	3.27e-06	0.000222	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS1—kidney cancer	3.24e-06	0.00022	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—kidney cancer	3.22e-06	0.000219	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSMD7—kidney cancer	3.18e-06	0.000216	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—BCHE—kidney cancer	3.01e-06	0.000204	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.97e-06	0.000202	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.87e-06	0.000195	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—kidney cancer	2.67e-06	0.000181	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.4e-06	0.000163	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—kidney cancer	2.33e-06	0.000158	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.27e-06	0.000154	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.27e-06	0.000154	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.2e-06	0.000149	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.09e-06	0.000142	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.64e-06	0.000111	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—POMC—kidney cancer	1.56e-06	0.000106	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.24e-06	8.42e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—kidney cancer	1.08e-06	7.34e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.63e-07	5.18e-05	CbGpPWpGaD
